Halia Therapeutics Appoints Gary Sabin as Executive Chairman and Adds Three Independent Directors to Board
Tremonton
Archived
•
May 19, 2026
•
2 views
Industry leaders join at a pivotal moment as company advances HT-6184 toward a pivotal trial in MDS and prepares Phase 2a initiation for HT-4253 in Alzheimer's disease
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
"Commision Art Work or Just pure Beauty."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Free Quote Today"
"We build AI or anything ICST"